Publications by Dr John Hanley - ePrints

Browsing publications by Dr John Hanley.

Newcastle Authors	Title	Year
Dr Sam Tingle Dr Emily Thompson Dr John Hanley Professor Colin Wilson	Interventions for preventing thrombosis in solid organ transplant recipients	2021
Dr Tina Biss Dr John Hanley	Therapeutic metamorphosis: Findings from a grounded theory study of the impact of low-dose prophylaxis in children living with haemophilia in India	2020
Dr Seun Anyiam Dr Maria McKenna Dr John Hanley	Junior doctor teaching delivered by near peers	2018
Dr Emma Kampouraki Dr Peter Avery Dr Hilary Wynne Dr Tina Biss Dr John Hanley et al.	Assessment of the efficacy of a novel tailored vitamin K dosing regimen in lowering the International Normalised Ratio in over-anticoagulated patients: A randomised clinical trial	2017
Dr John Hanley	Guidelines for the management of acute joint bleeds and chronic synovitis in haemophilia: A United Kingdom Haemophilia Centre Doctors' Organisation (UKHCDO) guideline	2017
Dr Louise MacDougall Dr John Hanley Dr Nicholas Thompson	UK practice in the prevention of central venous catheter-associated thrombosis in adults on home parenteral nutrition	2017
Dr John Hanley Dr Katherine Talks Dr Tina Biss Paul Fearon	Bilateral upper limb compartment syndrome induced by strenuous exercise in a patient with haemophilia A and a low titre inhibitor	2015
Dr John Hanley Dr Tina Biss Dr Katherine Talks Professor Colin Wilson	Interventions for preventing thrombosis in solid organ transplant recipients	2015
Professor Farhad Kamali Dr Hilary Wynne Dr Patrick Kesteven Dr John Hanley Dr Jing Shen et al.	Improving the safety and efficacy of anticoagulation therapy for thromboembolic disease through Vitamin K	2013
Dr Tina Biss Dr Peter Avery Julian Leathart Dr John Hanley Professor Ann Daly et al.	VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children	2011
Dr John Hanley	A United Kingdom haemophilia centre doctors' organization guideline approved by the British committee for standards in haematology: Guideline on the use of prophylactic factor VIII concentrate in children and adults with severe haemophilia A	2010
Dr Montserrat Briz Del Blanco Dr Katherine Talks Dr John Hanley Dr Patrick Kesteven Professor Ann Daly et al.	Reversal of warfarin-induced over-anticoagulation with individualized dosing of oral vitamin K: a pilot study	2010
Dr Valerie Wilson Dr John Hanley Dr Katherine Talks Dr Ann Curtis	Evaluation of a diagnostic service for haemophilia A incorporating the LightScanner high resolution melt analysis system	2009
Dr Katherine Talks Dr John Hanley Dr Patrick Kesteven Dr Peter Avery Professor Ann Daly et al.	Individualised oral vitamin K for reversal of warfarin excessive anticoagulation	2009
Professor Mark Baker Dr John Hanley Emeritus Professor Doug Turnbull Andrew Loughney	Hyperemesis gravidarum and first trimester sagittal sinus thrombosis	2008
Dr Patrick Kesteven Dr Katherine Talks Dr John Hanley	A retrospective audit of a standard protocol for the rapid reversal of warfarin in patients with intracranial haemorrhage	2007
Dr John Hanley	Proposed management of pregnancy and labour in an inherited platelet disorder, Glanzmann's thrombasthenia	2007
Dr Tina Biss Dr John Hanley	Use of recombinant factor VIIa (rFVIIa) in the management of intractable haemorrhage - A survey of current UK practice	2007
Dr John Hanley	An audit of thrombophilia screens: results from the National Pathology Alliance benchmarking review	2006
Dr Tina Biss Dr John Hanley	Clinical scoring systems to guide the use of recombinant activated factor VII (rFVIIa) in major haemorrhage	2006
Dr Tina Biss Dr Mark Velangi Dr John Hanley	Failure of rituximab to induce immune tolerance in a boy with severe haemophilia A and an alloimmune factor VIII antibody: a case report and review of the literature	2006
Diana Levett Professor Roderick Skinner Dr Andrew Hall Dr John Hanley	Novel mutations in a child with congenital amegakaryocytic thrombocytopenia	2006
Dr Tina Biss Dr John Hanley	Recombinant activated factor VII (rFVIIa/NovoSeven®) in intractable haemorrhage: Use of a clinical scoring system to predict outcome	2006
Dr Tina Biss Dr John Hanley Andrew Loughney	Recombinant activated factor VII in the management of major obstetric haemorrhage	2006
Andrew Loughney Professor Roy Taylor Dr John Hanley	The treatment of acute venous thromboembolism (VTE) in pregnancy. A retrospective study of experience in a single centre over 8 years	2005
Dr Tina Biss Dr John Hanley	The use of recombinant factor VIIa in the management of major haemorrhage: Experience within the northern region of the UK	2005
Dr Arun Natarajan Emerita Professor Sally Marshall Dr John Hanley Professor Azfar Zaman	Thrombogenicity of flowing blood is increased in patients with type 2 diabetes mellitus (T2DM) despite treatment with aspirin	2005
Dr John Hanley	UKHCDO acquired haemophilia study: A complete national cohort	2005
Dr John Hanley	Warfarin reversal	2004
Dr Tina Biss Dr Lucy Crossman Dr John Hanley	An acquired factor VIII inhibitor in association with a myeloproliferative/myelodysplastic disorder presenting with severe subcutaneous haemorrhage	2003
Dr Jonathan Wallis Dr John Hanley	Chronic relapsing thrombotic thrombocytopenic purpura due to a deficiency of von Willebrand factor-cleaving protease activity	2002
Diana Levett Dr Andrew Hall Dr John Hanley Professor Julie Irving	Comparitive study of conformation sensitive gel electrophoresis (CSGE) and denaturing high pressure liquid chromatography (DHPLC) for mutation detection in von Willebrands disease	2002
Dr John Hanley	The use of recombinant factor VIIA in a Jehovah's Witness with auto-immune thrombocytopenia and post-splenectomy haemorrhage	2002